Valentin Popov

Major health care providers in Latin America implement Devyser’s solutions to improve post-transplant healthcare management

IMSS, Mexico’s largest public health care provider and INP, Mexico’s National Institute of Pediatrics, now use Devyser’s solutions for chimerism monitoring of transplanted patients Stockholm 13 October 2020 – Devyser’s solutions are implemented in routine testing at Mexico’s largest public health care provider, IMSS, and Mexico’s National Institute of Pediatrics, INP. Both centers will be …

Major health care providers in Latin America implement Devyser’s solutions to improve post-transplant healthcare management Read More »

Devyser at DGTI 2020

Come and visit our virtual booth at DGTI! The 53rd annual meeting in Immunohaematology and Transfusion Medicine is taking place virtually from September 16th to 18th 2020. Visit our virtual booth to learn more about our upcoming solution for the non-invasive detection of fetal RHD status as well as Devyser Chimerism, our chimerism monitoring solution. …

Devyser at DGTI 2020 Read More »

Discover Devyser CFTR 68

https://vimeo.com/434385139/77bd5832b6 Discover Devyser CFTR 68, our latest kit for the analysis of the CFTR gene, capable of detecting up to 68 mutations most commonly associated with Cystic Fibrosis. List of mutations detected by Devyser CFTR 68 711+ 1G>T, 2043delG, 1677delTA, W1282X, R1283M, K710X, 3849+10kbC>T, 2789+5G>A, M1101K, G85E, 3905insT, 1525-1G>A, 2184delA, 3659delC, N1303K, 2184insA, 1812-1G->A, CFTRdele2,3, …

Discover Devyser CFTR 68 Read More »

Join our Q&A Poster viewings at the ESHG 2020 Virtual Conference!

The Q&A Poster viewing sessions at ESHG 2020 Virtual Conference will highlight two of our products: Devyser RHD, a non-invasive risk screening kit for RhD-negative mothers and Devyser Thalassemia, a single-tube NGS kit for Thalassemia detection. Devyser RHD Sunday, June 7th – 13.00 – 13.45 CEST P01.109.A: “A fast and non-invasive method for fetal RHD …

Join our Q&A Poster viewings at the ESHG 2020 Virtual Conference! Read More »

Devyser gears up for global sales of genetic tests — recruits Torbjörn Andersson as Chief Commercial Officer

Stockholm, 26 may 2020 — Devyser welcomes Torbjörn Andersson as Chief Commercial Officer in charge of global sales and marketing of Devyser’s genetic tests. Torbjörn has extensive experience in building and leading international sales organisations and distributor networks in the life science industry. He joins us most recently from Biotage AB where he was the Head …

Devyser gears up for global sales of genetic tests — recruits Torbjörn Andersson as Chief Commercial Officer Read More »